Skip to main content

#158338

EX2 Flp reporter cell line

Cat. #158338

EX2 Flp reporter cell line

Cat. #: 158338

Sub-type: Continuous

Unit size: 1x10^6 cells / vial

Availability: 10-12 weeks

Organism: Human

Tissue: Embryonic kidney

Model: Reporter

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Sergio F de Almeida

Institute: Instituto de Medicina Molecular Joo Lobo Antunes

Tool Details
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: EX2 Flp reporter cell line
  • Research fields: Cell biology;Genetics
  • Tool sub type: Continuous
  • Parental cell: Flp-In T-REx 293 cell line
  • Organism: Human
  • Tissue: Embryonic kidney
  • Model: Reporter
  • Conditional: No
  • Description: Derived from embryonic kidney cells
  • Production details: The pOG44 Flp-recombinase expression vector was co-transfected with the EX2 reporter construct into Flp-Inâ?‚„?‹Â˜ T-RExâ?‚„?‹Â˜ 293 cells
  • Recommended controls: Flp-In?‚™ T-REx?‚™ 293 cell line

Handling

  • Format: Frozen
  • Growth medium: Maintain under selection with 200 ?g/ml Hygromycin B (Roche) and 15 ?g/ml Blasticidin (InvivoGen) at 37?‚°C in a humidified atmosphere with 5% CO2.
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice

Related Tools

  • Related tools: EX2-AS Flp reporter cell line ; PROP Flp reporter cell line

References

  • Vtor et al. 2019. Sci Adv. 5(1):eaau1249. PMID: 30662944.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.